News

A&M Capital Partners' Strategic Acquisition of Asurint

A&M Capital Partners' Strategic Acquisition of Asurint

Exciting Acquisition Announcement: A&M Capital and Asurint

A&M Capital, a prominent multi-strategy private equity investment firm, has announced its acquisition of Asurint, a leading provider in the background screening solutions sector. This move signals a new chapter for Asurint, as A&M Capital Partners (AMCP) aims to drive growth and innovation in this essential industry.

Who is Asurint?

Founded in 2005 by visionaries Gregg Gay and Connie Clore, Asurint has made a mark by marrying advanced technology with insightful human analysis to furnish rapid and compliant background checks. Their platform serves a range of sectors including Employment, Tenant, and Government screening, establishing itself as an indispensable tool for numerous organizations.

The Vision Behind the Acquisition

Alla Schay, Asurint's CEO, expressed enthusiasm about the partnership, highlighting that A&M Capital recognizes the strength of their team and technology. She remarked, "This partnership will allow us to enhance our technology and introduce innovative capabilities aligned with our clients' evolving needs. It’s a fantastic opportunity for our workforce to advance and revolutionize our sector."

Building on a Strong Foundation

Gregg Gay reiterates confidence in his team, indicating that the acquisition will play a pivotal role in Asurint's future. The influx of capital is expected to fuel the next stage of growth and technological advancements, positioning Asurint for greater success.

Strategic Vision and Future Growth

A&M Capital’s investment is strategically designed to fuel Asurint’s expansion and innovation trajectory. This collaboration will enhance the company’s advanced screening technologies, broaden service capabilities, and strengthen its commitment to delivering outstanding experiences for clients and partners alike.

Exceptional Market Positioning

Jack McCarthy, Co-Founder and Managing Partner of A&M Capital, remarked on Asurint’s competitive edge, highlighting its compliance-first approach and the integration of modern technology with human insights. He believes that this partnership will further bolster Asurint's strong industry positioning and its ability to meet client needs effectively.

Future Plans and Investments

Alex Nivelle, a Partner at A&M Capital, conveyed excitement regarding working closely with Asurint's seasoned management to replicate the company’s successful growth through both organic measures and strategic acquisitions. He emphasized their goal to invest in proprietary technology and advanced solutions that maximize value for Asurint’s clientele.

Implications for Stakeholders

The transaction entails a significant shift in ownership, with Guidepost Growth Equity selling all its shares to A&M Capital following their initial investment in Asurint back in 2017. This transition points towards a robust future with new opportunities for both the company and its stakeholders.

Advice for Clients and Partners

Clients and partners can expect even greater dedication from Asurint as it leverages the capital and expertise from A&M Capital to enhance its services. The future looks bright as they continue to innovate within their already comprehensive service framework.

Conclusion: The Road Ahead

As Asurint embarks on this new journey, it stands poised to set new industry standards in background screening solutions. With A&M Capital's backing, clients can look forward to more innovative solutions that not only meet but exceed their expectations.

Frequently Asked Questions

What does the acquisition mean for Asurint's clients?

The acquisition will enhance Asurint’s ability to innovate and expand its service offerings, ensuring better experiences for clients.

What are Asurint's strengths in the background screening sector?

Asurint excels in integrating advanced technology with thorough human insights, leading to more accurate and compliant results.

How will A&M Capital contribute to Asurint's growth?

A&M Capital will provide capital investment and expertise in operational excellence to accelerate Asurint's strategic initiatives.

Is Asurint planning any new services post-acquisition?

Yes, Asurint aims to introduce new capabilities and solutions tailored to meet evolving client needs in the industry.

Who can I contact for more information about Asurint?

For inquiries, you can reach out to Kim Chochon, Vice President of Partnerships & Marketing at Asurint.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Adicet Bio Achieves Fast Track Status for Innovative ADI-001

Updated Category News Views 376

Adicet Bio's Recent FDA Fast Track Designation Adicet Bio, Inc. (Nasdaq: ACET), a pioneering company at the forefront of biotechnology, is thrilled to announce that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its investigational therapy ADI-001. This designation is a significant step forward for the company, especially in...

Continue Reading
Bank of Botetourt Reports Strong Financial Performance and Dividend Boost

Updated Category News Views 260

Bank of Botetourt Achieves Positive Financial Results Bank of Botetourt (OTCPK: BORT and BORTP) recently unveiled its impressive financial performance for the past year, highlighting strong profitability and growth. The bank announced that it generated a net income of $1,954,000, equating to $0.94 per basic share in the latest quarter. This marks an increase from...

Continue Reading
VERSES AI Partners with Kalosys to Transform Workforce Solutions

Updated Category News Views 173

VERSES AI Collaborates with Kalosys for Advanced AI Solutions In an exciting new venture, VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSD), a pioneering company in cognitive computing, has officially signed Kalosys, a provider of AI-driven IT solutions, as their newest enterprise customer. This partnership is set to elevate both companies as Kalosys looks to evolve into a...

Continue Reading
Safehold Expands Affordable Housing Initiatives in California

Updated Category News Views 217

Safehold's Commitment to Affordable Housing Development Safehold Inc. (NYSE: SAFE), recognized as a leader in the ground lease industry, has recently made significant strides in promoting affordable housing. The company has successfully closed a ground lease that will pave the way for the development of The Crawford, an affordable housing community aimed at meeting the...

Continue Reading
Codis Revolutionizes Spray Drying with New Global CDMO Services

Updated Category News Views 245

Codis Emerges as a New Leader in Global CDMO Services Introducing a pioneering global CDMO that merges advanced spray drying and particle engineering technologies under a unified brand. Formation and Specialization of Codis Codis has recently launched as a prominent global Contract Development and Manufacturing Organization (CDMO). This innovative company specializes in...

Continue Reading